Soressa Kitessa

Dr. Soressa Kitessa


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
SKSoressa Kitessa
Soressa Kitessa
MAMahinda Abeywardena
Mahinda Abeywardena
The skeletal muscle is the largest organ in the body. It plays a particularly pivotal role in glucose homeostasis, as it can account for up to 40% of the body and for up to 80%–90% of insulin-stimulated glucose disposal. Hence, insulin resistance (IR) in skeletal muscle has been a focus of much research and review. The fact that skeletal muscle IR precedes β-cell dysfunction makes it an ideal target for countering the diabetes epidemic. It is generally accepted that the accumulation of lipids in the skeletal muscle, due to dietary lipid oversupply, is closely linked with IR. Our understanding of this link between intramyocellular lipids (IMCL) and glycemic control has changed over the years. Initially, skeletal muscle IR was related to total IMCL. The inconsistencies in this explanation led to the discovery that particular lipid intermediates are more important than total IMCL. The two most commonly cited lipid intermediates for causing skeletal muscle IR are ceramides and diacylglycerol (DAG) in IMCL. Still, not all cases of IR and dysfunction in glycemic control have shown an increase in either or both of these lipids. In this review, we will summarise the latest research results that, using the lipidomics approach, have elucidated DAG and ceramide species that are involved in skeletal muscle IR in animal models and human subjects.

22 May 2014 in Nutrients
Verified
Journal Article
Open access
PDF file
SKSoressa Kitessa
Soressa Kitessa
MAMahinda Abeywardena
Mahinda Abeywardena
CWChakra Wijesundera
Chakra Wijesundera
PNPeter Nichols
Peter Nichols
Benefits of long-chain (≥C20) omega-3 oils (LC omega-3 oils) for reduction of the risk of a range of disorders are well documented. The benefits result from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); optimal intake levels of these bioactive fatty acids for maintenance of normal health and prevention of diseases have been developed and adopted by national and international health agencies and science bodies. These developments have led to increased consumer demand for LC omega-3 oils and, coupled with increasing global population, will impact on future sustainable supply of fish. Seafood supply from aquaculture has risen over the past decades and it relies on harvest of wild catch fisheries also for its fish oil needs. Alternate sources of LC omega-3 oils are being pursued, including genetically modified soybean rich in shorter-chain stearidonic acid (SDA, 18:4ω3). However, neither oils from traditional oilseeds such as linseed, nor the SDA soybean oil have shown efficient conversion to DHA. A recent breakthrough has seen the demonstration of a land plant-based oil enriched in DHA, and with omega-6 PUFA levels close to that occurring in marine sources of EPA and DHA. We review alternative sources of DHA supply with emphasis on the need for land plant oils containing EPA and DHA.

1 February 2004 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
SKSoressa Kitessa
Soressa Kitessa
SGSuresh K. Gulati
Suresh K. Gulati
GSGillian C. Simos
Gillian C. Simos
JAJohn R. Ashes
John R. Ashes
TSTrevor W. Scott
Trevor W. Scott
PWPeter C. Wynn
Peter C. Wynn
The present study was conducted to determine the pattern of incorporation of dietary EPA and docosahexaenoic acid (DHA) into milk, and to evaluate consequent changes in milk fat composition and sensory characteristics. Fourteen multiparous cows in early lactation were divided into two groups and were offered supplements for 10 d. While individual stalls after each morning milking, one group was offered a mixture of rumen-protected tuna oil (RPTO)–soyabean supplement (2 kg; 30:70, w/w; +RPTO) and the second group was offered the basal ration without RPTO (−RPTO). Both groups grazed together on a spring pasture after supplementation. Feeding supplemental RPTO increased the concentrations of EPA and DHA in milk fat from undetectable levels in −RPTO cows to 6·9 and 10·1 g/kg milk fat respectively. Total n-3 PUFA concentration in milk fat was increased three- to fourfold by tuna-oil supplementation (8·4 to 32·0 g/kg milk fat). There were no significant effects on milk production (35·4 v. 33·9 l/d), milk protein (28·2 v. 30·1 g/kg) or milk fat (36·2 v. 40·4 g/kg for −RPTO and +RPTO respectively). The concentration of total saturated fatty acids in milk fat was significantly reduced (568 v. 520 g/kg total fatty acids) and there was a 17 % reduction in the atherosclerotic index of milk after tuna-oil supplementation. Untrained consumer panellists (n 61) rated milk from both groups of cows similarly for taste and smell. We conclude that it is possible to enrich milk with n-3 PUFA without deleterious effects on yield, milk composition or sensory characteristics.

11 February 2010 in Animal Production Science
Verified
Journal Article
Closed access
PDF file
SKSoressa Kitessa
Soressa Kitessa
SLShimin Liu
Shimin Liu
JBJan Briegel
Jan Briegel
DPDavid Pethick
David Pethick
GGGraham Gardner
Graham Gardner
DHDavid Hopkins
David Hopkins
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the n-3 polyunsaturated fatty acids (n-3 PUFA) for which there is ample evidence of human health benefits, and these are also the fatty acids for which there are cut-off points for ‘source’ and ‘good source’ claims. Two consecutive experiments were conducted to determine the effect of finishing systems on the n-3 PUFA content of lamb meat in Western Australia. In experiment I, a 4-week feeding experiment was conducted using 48 Poll Dorset × Merino lambs. The lambs were divided into two lots of 24 (12 males and 12 females) and randomly assigned to either concentrate (C1) finishing on commercial lamb finishing pellets or pasture (P) finishing on kikuyu (Pennisetum clandestinum) pasture. In experiment II, 28 lambs were divided into two groups of 14 lambs (seven males and seven females) and assigned to finishing either on concentrate pellets (C2) or concentrate pellets plus linseed (C2-L). This second experiment was conducted indoors for 10 weeks. The initial liveweight (mean ± s.e.) of the lambs was 43 ± 0.6 and 32.5 ± 0.9 kg for experiments I and II, respectively. At the end of experiment II, three chops each were sampled from the leg, loin, forequarter and neck region of each carcass. The final liveweight (42 ± 0.8 v. 50 ± 1.2 kg), hot carcass weight (19 ± 0.5 v. 24 ± 0.7 kg) and GR depth (5.6 ± 0.6 v. 12.8 ± 0.6 mm) were lower (P < 0.05) for P than C1 lambs. In contrast, C2 and C2-L lambs had similar final liveweight (44 ± 0.7 v. 45 ± 0.9 kg), hot carcass weight (19 ± 0.3 v. 20 ± 0.5 kg) and GR depth (13 ± 1.3 v. 14 ± 1.2 mm). In experiment I, the total n-3 PUFA yields for C1 and P lambs in the M. longissimus lumborum were 67 ± 2.5 and 78 ± 3.2 mg per 100 g muscle, respectively. The EPA plus DHA yields were 17 and 21 mg per 100 g muscle, respectively. The sum of the long-chain (=C20) n-3 PUFA EPA, docosapentaenoic acid and DHA for C1 and P lambs were 30 and 37 mg per 100 g, respectively. Sex had no effect on any of the n-3 fatty acids. In experiment II, the total n-3 PUFA yields for C2 lambs were 61, 54, 60 and 104 mg per 100 g for leg, loin, forequarter and neck chops, respectively. The respective values for C2-L lambs were 153, 138, 139 and 178 mg per 100 g muscle. The claimable EPA plus DHA yields for C2 lambs were 13, 10, 12 and 15 mg per 100 g of trimmed leg, loin, forequarter and neck chops, respectively. The respective values for C2-L lambs were around 2-fold higher at 27, 21, 25 and 23 mg per 100 g raw meat. All the samples from pasture-finished and linseed-supplemented groups met the 30 mg cut-off point for ‘source’ claim in Australia when the computation was based on 100 g cooked lamb serve (140 g raw). We conclude that pasture-finished lambs have more n-3 PUFA per serve than their counterparts finished indoors on commercial pellets. Further, supplementing indoor-finished lambs with linseed provided equivalent n-3 PUFA per serve to finishing lambs on pasture. Supplementation with an omega-3 source improved omega-3 per serve across the whole carcass irrespective of sex.

11 July 2008 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
SKSoressa Kitessa
Soressa Kitessa
PYPaul Young
Paul Young
α-Linolenic acid (ALA; 18 : 3n-3) and stearidonic acid (SDA; 18 : 4n-3) are on the biosynthetic pathway of EPA (20 : 5n-3) and DHA (22 : 6n-3). Then-3 fatty acid in rapeseed oil is ALA while Echium oil contains both ALA and SDA. To determine the comparative efficacy of ALA- and SDA-rich oils in enriching broiler meat withn-3 PUFA, we offered diets supplemented with rapeseed oil (rapeseed group) or Echium oil (Echium group) for 35 d to two groups of chicks (age 21 d). There were no differences in carcass weight (2·20 (sem0·06)v.2·23 (sem0·05) kg), boned, skinless thigh muscle (494 (sem20·5)v.507 (sem16·7) g), boned, skinless breast muscle (553 (sem13·4)v.546 (sem11·6) g) or organ weights (heart, liver and gizzard) between the two groups. The total intramuscular fat (IMF) percentage of thigh (8·0 (sem0·64)v.8·1 (sem0·62) %) and breast muscles (2·3 (sem0·24)v.2·0 (sem0·19) %) were also similar between the groups. In contrast, the concentrations of most of the individualn-3 fatty acids (ALA, SDA, EPA and docosapentaenoic acid) were all higher in the Echium than the rapeseed group (P < 0·05). However, differences in DHA concentrations were significant in breast but not thigh muscle IMF. The totaln-3 yields/100 g serve thigh muscle were 265 and 676 mg for the rapeseed and Echium groups, respectively (P < 0·0001). The corresponding values for equivalent breast muscles were 70 and 137 mg, respectively (P < 0·01). We conclude that Echium oil is a better lipid supplement than rapeseed oil in changing the concentration and yield ofn-3 fatty acids, except DHA, in broiler meat.

2 January 2014 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
PNPeter Nichols
Peter Nichols
SKSoressa Kitessa
Soressa Kitessa
MAMahinda Abeywardena
Mahinda Abeywardena
Considerable interest exists presently in comparing the performance of krill oil (KO) and fish oil (FO) supplements. Ramprasath et al. (Lipids Health Dis 12: 178, 2013) have recently compared use of KO and FO in a trial with healthy individuals to examine which oil is more effective in increasing n-3 PUFA, decreasing the n-6:n-3 ratio and improving the omega-3 index. The authors concluded that KO was more effective than FO for all three criteria. However, careful examination of the fatty acid profiles of the oils used showed that the FO used was not a typical FO; it contained linoleic acid as the dominant fatty acid (32%) and an n-6:n-3 ratio of >1. Due to the fatty acid profile being non-representative of typically commercially marketed FO, the conclusions presented by Ramrasath et al. (Lipids Health Dis 12: 178, 2013) are not justified and misleading. Considerable care is needed in ensuring that such comparative trials do not use inappropriate ingredients.